Toobit lists CUDIS (CUDIS) for spot trading

Dear Toobiters,

We are thrilled to announce that Toobit is listing CUDIS (CUDIS) on Toobit Spot.

The listing schedule is as follows:

1. Deposits: Opened
2. Trading: Opened
3. Withdrawals: 2025-08-22
4. Spot trading link: CUDIS/USDT
5. Trading Zone: AI & RWA

About CUDIS

Aiming to extend the health-span to 140 years, CUDIS is building the first-ever Longevity protocol, designed to make longevity trackable, personalized, and rewarding. Through the integration of the CUDIS Ring, an AI-powered Longevity Hub, and a blockchain-driven Super App, users gain full ownership of their health data, real-time longevity insights, and economic incentives for optimizing their biological health. CUDIS is building a new longevity ecosystem with realistic and effective products, programs and services with partners around the world.

Transaction Network (BSC): https://bscscan.com/token/0xC1353D3Ee02FDbd4f65F92EEe543cfd709049CB1

Website | Whitepaper | X

Small balance conversion

1. Small balance conversion will list CUDIS on 2025-08-21 (UTC).

We are excited to welcome the CUDIS community to Toobit and look forward to a successful launch. Thank you for your continued support.

Toobit Team

2025-08-21

Download the Toobit app now

Find us:

X: https://x.com/Toobit_official

Telegram: https://t.me/Toobit_EN

Discord: https://discord.com/invite/vvxTuGTz

YouTube: https://www.youtube.com/@Toobit_official

Reddit: https://www.reddit.com/r/toobit/

Facebook: https://www.facebook.com/toobitofficial

Medium: https://medium.com/toobit-exchange

Toobit reserves the right to modify or cancel this announcement at any time and for any reason without prior notice.

Risk Warning: The prices of digital assets may fluctuate significantly. The value of your investment may increase or decrease, and you may even lose the entire amount invested. You are solely responsible for your investment decisions, and Toobit is not liable for any losses that may occur due to the use of margin trading. This information should not be considered financial or investment advice. Please refer to our Terms of Use and Risk Disclosure for more details.